Clinical Trials Directory

Trials / Sponsors / Enyo Pharma

Enyo Pharma

Industry · 12 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingPharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt and Evaluation of Potential Drug-Drug Interac
Healthy Adult Male and Female Volunteers
Phase 12025-10-28
RecruitingVonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steato
Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 3, Metabolic Dysfunction-Associated Steatohepatitis
Phase 22025-07-01
CompletedVonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1)
Alport Syndrome
Phase 22024-08-01
CompletedA Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chron
Hepatitis B, Chronic
Phase 22020-05-25
TerminatedStudy of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD)
Hepatitis B, Chronic
Phase 22020-05-12
CompletedMass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-EYP001a After a Single Ora
Healthy
Phase 12019-07-24
CompletedSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of EYP001a in Healthy Volunteers and Nonalcoholic
NASH - Nonalcoholic Steatohepatitis, Healthy
Phase 12019-06-11
CompletedSafety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (
Non-alcoholic Steatohepatitis
Phase 22019-01-30
CompletedDrug Drug Interaction Study for EYP001 With Entecavir
Hepatitis B, Chronic
Phase 12018-02-12
CompletedEvaluation of the Safety and Pharmacology of EYP001 in HBV Subjects
Hepatitis B, Chronic
Phase 12017-09-21
CompletedEYP001a Food Effect Study in Subjects With Chronic Hepatitis B Virus (HBV) Infection
Hepatitis B, Chronic
Phase 12017-02-10
CompletedStudy Evaluating Safety, Tolerability and Pharmacokinetics of EYP001a in Healthy Male Subjects
Healthy
Phase 12016-08-01